TY - CHAP
T1 - Drugs acting on the cerebral and peripheral circulations.
AU - Mangoni, Arduino
PY - 2012
Y1 - 2012
N2 - This review of the 2010 publications on drugs that act on the cerebral and peripheral circulations covers flunarizine, the triptans, and inhibitors of phosphodiesterase type V, and there is a special review on diosmin and hidrosmin. A progressive supranuclear palsy-like syndrome has been reported in a patient taking flunarizine and amiodarone; the signs and symptoms resolved almost completely after drug withdrawal. A post hoc analysis of the Norwegian Mother and Child Cohort Study showed no significant association between the use of triptans during the first semester and congenital malformations. However, the use of triptans during the second and/or third semester was associated with an increased risk of atonic uterus and significant blood loss during labor. In a comparison of the three main inhibitors of phosphodiesterase type 5, sildenafil, tadalafil, and vardenafil, there were no significant differences in the incidences of adverse reactions, but those who used tadalafil had a significantly longer mean duration of adverse reactions (15 hours) than sildenafil (3.9 hours) and vardenafil (7.7 hours).
AB - This review of the 2010 publications on drugs that act on the cerebral and peripheral circulations covers flunarizine, the triptans, and inhibitors of phosphodiesterase type V, and there is a special review on diosmin and hidrosmin. A progressive supranuclear palsy-like syndrome has been reported in a patient taking flunarizine and amiodarone; the signs and symptoms resolved almost completely after drug withdrawal. A post hoc analysis of the Norwegian Mother and Child Cohort Study showed no significant association between the use of triptans during the first semester and congenital malformations. However, the use of triptans during the second and/or third semester was associated with an increased risk of atonic uterus and significant blood loss during labor. In a comparison of the three main inhibitors of phosphodiesterase type 5, sildenafil, tadalafil, and vardenafil, there were no significant differences in the incidences of adverse reactions, but those who used tadalafil had a significantly longer mean duration of adverse reactions (15 hours) than sildenafil (3.9 hours) and vardenafil (7.7 hours).
KW - Adverse reactions
KW - Diosmin and hidrosmin
KW - Flunarizine
KW - Phosphodiesterase type V inhibitors
KW - Triptans
UR - http://www.scopus.com/inward/record.url?scp=84872401514&partnerID=8YFLogxK
U2 - 10.1016/B978-0-444-59499-0.00019-2
DO - 10.1016/B978-0-444-59499-0.00019-2
M3 - Chapter
SN - 9780444594990
T3 - Side Effects of Drugs Annual
SP - 311
EP - 316
BT - Side Effects of Drugs Annual
PB - Elsevier
ER -